In human lung cancers, cytoplasmic localization of PRMT5 was found to correlate with high-grade tumors, whereas PRMT5 nuclear localization was more frequent in well-differentiated carcinoid tumors [29]. The gene discussed is PRMT5; the disease is lung cancer.